ICON ROA 2010-2025 | ICLR
Current and historical return on assets (ROA) values for ICON (ICLR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| ICON ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.76B | $16.72B | 4.47% |
| 2024-12-31 | $0.79B | $16.88B | 4.65% |
| 2024-09-30 | $0.75B | $17.21B | 4.38% |
| 2024-06-30 | $0.71B | $16.97B | 4.20% |
| 2024-03-31 | $0.68B | $17.05B | 4.01% |
| 2023-12-31 | $0.61B | $16.99B | 3.58% |
| 2023-09-30 | $0.51B | $17.03B | 3.00% |
| 2023-06-30 | $0.51B | $17.11B | 2.97% |
| 2023-03-31 | $0.51B | $17.29B | 2.97% |
| 2022-12-31 | $0.51B | $17.19B | 2.95% |
| 2022-09-30 | $0.46B | $17.13B | 2.70% |
| 2022-06-30 | $0.21B | $17.04B | 1.21% |
| 2022-03-31 | $0.17B | $17.16B | 1.20% |
| 2021-12-31 | $0.15B | $17.39B | 1.45% |
| 2021-09-30 | $0.18B | $17.66B | 2.53% |
| 2021-06-30 | $0.36B | $3.58B | 10.74% |
| 2021-03-31 | $0.34B | $3.47B | 10.54% |
| 2020-12-31 | $0.33B | $3.44B | 10.92% |
| 2020-09-30 | $0.33B | $3.07B | 11.34% |
| 2020-06-30 | $0.33B | $2.86B | 11.77% |
| 2020-03-31 | $0.38B | $2.84B | 13.48% |
| 2019-12-31 | $0.37B | $2.91B | 13.63% |
| 2019-09-30 | $0.36B | $2.75B | 13.93% |
| 2019-06-30 | $0.35B | $2.72B | 14.11% |
| 2019-03-31 | $0.33B | $2.61B | 14.08% |
| 2018-12-31 | $0.32B | $2.35B | 14.24% |
| 2018-09-30 | $0.31B | $2.33B | 13.81% |
| 2018-06-30 | $0.30B | $2.17B | 13.73% |
| 2018-03-31 | $0.29B | $2.22B | 13.84% |
| 2017-12-31 | $0.28B | $2.15B | 14.12% |
| 2017-09-30 | $0.28B | $2.05B | 14.87% |
| 2017-06-30 | $0.27B | $1.90B | 14.64% |
| 2017-03-31 | $0.27B | $1.86B | 14.73% |
| 2016-12-31 | $0.26B | $1.83B | 14.41% |
| 2016-09-30 | $0.25B | $1.90B | 14.07% |
| 2016-06-30 | $0.25B | $1.75B | 14.13% |
| 2016-03-31 | $0.25B | $1.80B | 14.25% |
| 2015-12-31 | $0.24B | $1.72B | 14.24% |
| 2015-09-30 | $0.23B | $1.81B | 14.04% |
| 2015-06-30 | $0.22B | $1.64B | 13.81% |
| 2015-03-31 | $0.20B | $1.61B | 12.90% |
| 2014-12-31 | $0.18B | $1.53B | 11.84% |
| 2014-09-30 | $0.16B | $1.57B | 10.62% |
| 2014-06-30 | $0.14B | $1.53B | 9.49% |
| 2014-03-31 | $0.12B | $1.49B | 8.53% |
| 2013-12-31 | $0.10B | $1.44B | 7.66% |
| 2013-09-30 | $0.09B | $1.36B | 7.08% |
| 2013-06-30 | $0.08B | $1.29B | 6.58% |
| 2013-03-31 | $0.07B | $1.23B | 6.08% |
| 2012-12-31 | $0.06B | $1.20B | 5.34% |
| 2012-09-30 | $0.04B | $1.14B | 4.00% |
| 2012-06-30 | $0.02B | $1.11B | 2.13% |
| 2012-03-31 | $0.02B | $1.13B | 2.18% |
| 2011-12-31 | $0.02B | $1.04B | 2.14% |
| 2011-09-30 | $0.04B | $1.05B | 3.98% |
| 2011-06-30 | $0.06B | $1.01B | 6.44% |
| 2011-03-31 | $0.07B | $1.01B | 7.72% |
| 2010-12-31 | $0.09B | $0.95B | 9.49% |
| 2010-09-30 | $0.10B | $0.94B | 10.59% |
| 2010-06-30 | $0.10B | $0.88B | 11.08% |
| 2010-03-31 | $0.10B | $0.90B | 10.60% |
| 2009-12-31 | $0.10B | $0.91B | 10.62% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.241B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.621B | 26.94 |
| CVS Health (CVS) | United States | $84.680B | 10.52 |
| Elevance Health (ELV) | United States | $78.955B | 10.19 |
| Cencora (COR) | United States | $57.765B | 20.10 |
| DiDi Global (DIDIY) | China | $23.297B | 24.75 |
| Natera (NTRA) | United States | $21.640B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.549B | 17.48 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.690B | 0.00 |
| Solventum (SOLV) | United States | $12.990B | 13.75 |
| CochLear (CHEOY) | Australia | $12.847B | 0.00 |
| Revvity (RVTY) | United States | $11.865B | 20.42 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.370B | 13.61 |
| Medpace Holdings (MEDP) | United States | $9.269B | 24.62 |
| HealthEquity (HQY) | United States | $8.917B | 39.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.417B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.779B | 15.24 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.688B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.952B | 29.17 |
| BrightSpring Health Services (BTSG) | United States | $3.769B | 34.58 |
| Sotera Health (SHC) | United States | $3.290B | 18.69 |
| Surgery Partners (SGRY) | United States | $2.853B | 37.10 |
| Alignment Healthcare (ALHC) | United States | $2.712B | 0.00 |
| Concentras Parent (CON) | United States | $2.615B | 15.11 |
| Organon (OGN) | United States | $2.587B | 2.75 |
| GeneDx Holdings (WGS) | United States | $2.432B | 93.65 |
| Progyny (PGNY) | United States | $2.080B | 45.79 |
| PACS (PACS) | United States | $1.972B | 0.00 |
| Ardent Health (ARDT) | United States | $1.970B | 8.40 |
| Premier (PINC) | United States | $1.805B | 13.70 |
| GoodRx Holdings (GDRX) | United States | $1.729B | 34.57 |
| Teladoc Health (TDOC) | United States | $1.493B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.271B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.159B | 8.82 |
| CareDx (CDNA) | United States | $1.072B | 16.74 |
| Agilon Health (AGL) | United States | $0.989B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| Nutex Health (NUTX) | United States | $0.766B | 11.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.610B | 4.11 |
| InnovAge Holding (INNV) | United States | $0.574B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| SBC Medicals (SBC) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.465B | 10.47 |
| Omada Health (OMDA) | $0.450B | 0.00 | |
| So-Young (SY) | China | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.370B | 30.42 |
| Performant Healthcare (PHLT) | United States | $0.333B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.324B | 0.00 |
| Beauty Health (SKIN) | United States | $0.265B | 0.00 |
| Oncology Institute (TOI) | United States | $0.223B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 25.83 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| KindlyMD (NAKA) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.067B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.055B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.034B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |